版本:
中国

BRIEF-Akers Biosciences reports preliminary unaudited earnings highlights for fiscal year 2016

March 30 Akers Biosciences Inc

* Akers Biosciences reports preliminary unaudited earnings highlights for fiscal year 2016

* Akers Biosciences Inc - "expect 2017 to be characterized by further growth in our flagship PIFA heparin PF/4 rapid assay product line" Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐